Tag:

Illumina

Latest Headlines

Latest Headlines

J&J, AstraZeneca and Sanofi join Illumina to create a pan-cancer test

Pharma giants AstraZeneca, Johnson & Johnson and Sanofi have teamed up with gene sequencing pioneer Illumina to create a single test that screen patients for a wealth of cancer-related gene variants, allowing drugmakers to identify the ideal recipients of their oncology drugs.

Illumina, AstraZeneca, Janssen and Sanofi to pursue universal companion Dx test

Illumina has inked deals with three major Big Pharma companies with a goal of developing a universal gene-sequencing companion diagnostic test system focused on cancer.

Oxford Nanopore raises $59M for pocket-sized molecular analysis

Oxford Nanopore has raised a huge amount of money for a very tiny technology--about $302 million in total since it was founded in 2005. But despite an unclear commercial timeline for this private, U.K. company, investors have piled in again with £35 million ($59 million).

AllSeq, DNAnexus share data from Illumina HiSeq X Ten

While early adopters of Illumina's $1,000 genome machine the HiSeq X Ten have been testing the system for months, researchers from less wealthy organizations have had no access to the technology. In a limited way that changed this week, when the Garvan Institute of Medical Research, DNAnexus and AllSeq teamed up to share data from a HiSeq X Ten.

Illumina to invest $273M in U.K. after striking genome-sequencing deal

The British government has unveiled a major funding boost for its 100,000 Genomes Project, with a further $506 million (£300 million) set to be spent over the next four years. Illumina is responsible for more than half of the cash, with the U.S. sequencing giant due to invest $273 million in England.

Illumina strikes sequencing deal with England's 100K Genome Project

When Illumina unveiled its HiSeq X Ten in January, the alignment between its capabilities and the needs of England's 100K Genome Project were clear. The project aims to sequence 100,000 genomes by 2017 for around $160 million, figures that only look achievable using the massive output and relatively low costs of the HiSeq X Ten. This week the tie-up became official.

Illumina working to turn smartphones into 'molecular stethoscopes'

While Apple, Google and Samsung are all trying to persuade people to use their mobile technology to create personal health hubs, Illumina plans to take the concept further still. The genomic giant is working to turn smartphones into "molecular stethoscopes" that could change how patients interact with the healthcare and research ecosystems.

Chinese upstart takes aim at Illumina with homegrown DNA sequencer

Having seen off Roche's 454 Life Sciences and established a big lead over its remaining rivals, Illumina now faces a new challenger for the DNA sequencing market.

Illumina launches innovative sequencing technology for genetic prescreening of embryos

Fresh on the heels of promising Q1 numbers, Illumina is launching its innovative sequencing technology for the preimplantation genetic screening (PGS) of embryos.

Ariosa faces new patent pushback from rival Illumina

Ariosa Diagnostics is facing legal pushback after filing plans for a $60 million IPO to support development of its prenatal genetic test. Illumina filed a new patent infringement suit against the company, seeking an injunction against the company's noninvasive diagnostic tool.